Royce & Associates’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-4
| Closed | -$248K | – | 1219 |
|
|
2018
Q2 | $248K | Hold |
4
| – | – | ﹤0.01% | 1044 |
|
|
2018
Q1 | $1.65M | Hold |
4
| – | – | 0.01% | 888 |
|
|
2017
Q4 | $1.09M | Hold |
4
| – | – | 0.01% | 961 |
|
|
2017
Q3 | $1.07M | Hold |
4
| – | – | 0.01% | 946 |
|
|
2017
Q2 | $1.2M | Buy |
4
+1
| +33% | +$301K | 0.01% | 930 |
|
|
2017
Q1 | $1.07M | Buy |
3
+2
| +200% | +$711K | 0.01% | 972 |
|
|
2016
Q4 | $360K | Buy |
+1
| New | +$360K | ﹤0.01% | 1024 |
|
|
2016
Q3 | – | Hold |
0
| – | -$22K | – | 1076 |
|
|
2016
Q2 | – | Hold |
0
| – | -$24K | – | 1081 |
|
|
2016
Q1 | – | Hold |
0
| – | -$27K | – | 1085 |
|
|
2015
Q4 | – | Hold |
0
| – | -$26K | – | 1115 |
|
|
2015
Q3 | – | Hold |
0
| – | -$38K | – | 1182 |
|
|
2015
Q2 | – | Hold |
0
| – | -$43K | – | 1193 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 1198 |
|